.
|
Report Date : |
29.01.2014 |
IDENTIFICATION DETAILS
|
Name : |
FARMACHEM SA MACHINERIES AND MARKETING |
|
|
|
|
Registered Office : |
Via Rime 38 6850 Mendrisio/TI |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
22.02.1991 |
|
|
|
|
Com. Reg. No.: |
514.3.005.940-5 / 252959 |
|
|
|
|
Legal Form : |
Company limited by shares |
|
|
|
|
Line of Business : |
Trading in pharmaceutical and medical products |
|
|
|
|
No. of Employees : |
16 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
Payment Behaviour : |
Unknown |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2013
|
Country Name |
Previous Rating (30.06.2013) |
Current Rating (30.09.2013) |
|
Switzerland |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
SWITZERLAND - ECONOMIC OVERVIEW
Switzerland is a peaceful, prosperous, and modern market economy with low unemployment, a highly skilled labor force, and a per capita GDP among the highest in the world. Switzerland's economy benefits from a highly developed service sector, led by financial services, and a manufacturing industry that specializes in high-technology, knowledge-based production. Its economic and political stability, transparent legal system, exceptional infrastructure, efficient capital markets, and low corporate tax rates also make Switzerland one of the world's most competitive economies. The Swiss have brought their economic practices largely into conformity with the EU's to enhance their international competitiveness, but some trade protectionism remains, particularly for its small agricultural sector. The fate of the Swiss economy is tightly linked to that of its neighbors in the euro zone, which purchases half of all Swiss exports. The global financial crisis of 2008 and resulting economic downturn in 2009 stalled export demand and put Switzerland in a recession. The Swiss National Bank (SNB) during this period effectively implemented a zero-interest rate policy to boost the economy as well as prevent appreciation of the franc, and Switzerland's economy recovered in 2010 with 3.0% growth. The sovereign debt crises currently unfolding in neighboring euro-zone countries pose a significant risk to Switzerland's financial stability and are driving up demand for the Swiss franc by investors seeking a safe-haven currency. The independent SNB has upheld its zero-interest rate policy and conducted major market interventions to prevent further appreciation of the Swiss franc, but parliamentarians have urged it to do more to weaken the currency. The franc's strength has made Swiss exports less competitive and weakened the country's growth outlook; GDP growth fell to 1.9% in 2011 and 0.8% in 2012. Switzerland has also come under increasing pressure from individual neighboring countries, the EU, the US, and international institutions to reform its banking secrecy laws. Consequently, the government agreed to conform to OECD regulations on administrative assistance in tax matters, including tax evasion. The government has renegotiated its double taxation agreements with numerous countries, including the US, to incorporate the OECD standard, and is considering the possibility of imposing taxes on bank deposits held by foreigners. These steps will have a lasting impact on Switzerland's long history of bank secrecy
|
Source
: CIA |
FARMACHEM SA
MACHINERIES AND MARKETING
"FARMACHEM SA M&M"
Via Rime 38
6850 Mendrisio/TI
Switzerland/CH
Telephone: 091
9111000
Fax: 091
9111009
Web
site: http://www.farmachem.ch
E-mail: customerserv@farmachem.ch
WIN
Worldbox No.: CH0000343787
VAT-No.: CHE106758389
Established: 1991
Line
of Business: Consumer goods
wholesale
Industry
Division: Wholesale trade
Industry-code (NACE): 4646 Wholesale of pharmaceutical goods
Import/Export: Import, Export
Export
sales: 99,0%
Banks: unknown
Organisation
level: Ultimate Parent
Coverage: Company
Figures: approximately
Employees: 16
Sales: CHF 40-60 Mio
The business activities includes trading in
pharmaceutical and medical products.
Information on property ownership was not
available.
Company
No: 514.3.005.940-5 /
252959
Legal
form: Company limited
by shares
Registration: 22.02.1991
Legal
status: active
Responsible
Register: Registro di commercio del
Cantone Ticino (since 19.12.2002)
History: Date of Statutes:
24.07.1998
Date of
Statutes: 20.05.1992
Date of
Statutes: 29.11.1995
Date of
Statutes: 18.12.2002
Date of
Incorporation Statutes: 08.02.1991
Date of
Statutes: 22.12.2009
Date of
Statutes: 26.02.2010
Entry Deleted Name
active Farmachem
SA Machineries and Marketing
Entry Deleted Legal domicile
19.12.2002 Mendrisio,
Switzerland
19.12.2002 Lugano, Switzerland
Entry Deleted Address
19.12.2002 Via
Rime 38, 6850 Mendrisio/TI, Switzerland/CH
19.12.2002 via Zurigo 35, 6900 Lugano/TI, Switzerland/CH
Entry Deleted Capital
01.03.2010 Share
Capital CHF 555,000, paidup CHF 555,000
01.03.2010 Share Capital CHF 500,000, paidup CHF 500,000
Entry Deleted Capital Structure
26.02.2010 555
Bearer shares of CHF 1,000.--
26.02.2010 500 Bearer shares of CHF 1,000.--
Entry Deleted Activity (original Language)
active La
commercializzazione di prodotti farmaceutici/medico e sanitari, l'attività
d'agente nel settore, la partecipazione a società che abbiano il medesimo scopo
sociale. Vendita e progettazione di impianti, rappresentanze e vendita di macchinari
dell'industria chimica e farmaceutica, additivi per cosmesi e per l'industria
delle vernici e della gomma.
Entry Deleted Remarks (original Language)
active Publishing
authority: FUSC.
01.03.2010 Capital:
Aumento ordinario.
01.03.2010 Reports:
Le comunicazioni e convocazioni della società agli azionisti, se noti,
avvengono mediante comunicazione scritta, via fax, e-mail o altro mezzo
elettronico.
Title Name
President Tiziano
Trazzi, Origin: , Italy, Residential
address: Como, Italy, single signature
Director Paolo
Tettamanti, Origin: Muggio, Switzerland, Residential address: 6900 Lugano/TI,
Switzerland, single signature
Director Veljko
Zorzut, Origin: Croatia, Residential address: Coldrerio/TI, Switzerland, single
signature, Registered since: 11.11.2010
Title Name
Auditor Fidirevisa
SA, Residential address: Lugano, Switzerland
Title Name
Chief
Executive Officer Paolo
Tettamanti
No.
of Owner/-s: 1
Owner: The company is
privately owned.
Class: 100%
Type: direct
Name: Tiziano Trazzi
City/Country: Como, Italy/IT
Interest: 100,00% voting right,
100,00% capital interest
Class: 100%
Name: Farmachem SA
Machineries and Marketing
City/Country: Brno-město, Czech/CZ
Interest: 100,00% voting right,
100,00% capital interest
Class: 50-100%
Name: HYDERABAD FARMECH PVT
LTD
City/Country: HYDERABAD/Andhra Pradesh,
India/IN
Interest: 70,00% voting right,
70,00% capital interest
Class: 50-100%
Name: EXPLORA LABORATORIES
SA
City/Country: Mendrisio/TI, Switzerland/CH
Interest: 64,00% voting right,
64,00% capital interest
Class: 20-29%
Name: Delta Biotech SA
City/Country: Buenos Aires, Argentina/AR
Interest: 24,00% voting right,
24,00% capital interest
Control date Year No. Amount CHF Status
17.06.2009 2009 0
17.06.2009 2008 0
17.06.2009 2007 0
17.06.2009 2006 0
17.06.2009 2005 0
17.06.2009 2004 0
An updated legal action check is only available
against proof of interest. e.g. a copy of an enquiry letter, and order or
invoice relating to the subject company.
Credit Information
Financial
Statements: The company does not
disclose any financial statements. Third parties are not permitted any insight
into the financial affairs. It is therefore difficult to make a proper
assessment of the actual situation.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.99 |
|
|
1 |
Rs.104.61 |
|
Euro |
1 |
Rs.86.17 |
INFORMATION DETAILS
|
Report Prepared
by : |
NIS |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to
overcome financial difficulties seems comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.